MC1601A1 - Nouveaux derives de thiazolidine - Google Patents
Nouveaux derives de thiazolidineInfo
- Publication number
- MC1601A1 MC1601A1 MC841709A MC1709A MC1601A1 MC 1601 A1 MC1601 A1 MC 1601A1 MC 841709 A MC841709 A MC 841709A MC 1709 A MC1709 A MC 1709A MC 1601 A1 MC1601 A1 MC 1601A1
- Authority
- MC
- Monaco
- Prior art keywords
- fluoro
- benzopyran
- thiazolidine
- dihydro
- dioxospiro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH343283 | 1983-06-23 | ||
| CH186084 | 1984-04-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1601A1 true MC1601A1 (fr) | 1985-05-09 |
Family
ID=25688868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC841709A MC1601A1 (fr) | 1983-06-23 | 1984-06-20 | Nouveaux derives de thiazolidine |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4587256A (da) |
| EP (1) | EP0129747A3 (da) |
| AU (1) | AU2947784A (da) |
| DK (1) | DK277484A (da) |
| ES (4) | ES8602820A1 (da) |
| FI (1) | FI842327L (da) |
| HU (1) | HUT34509A (da) |
| IL (1) | IL72139A0 (da) |
| MC (1) | MC1601A1 (da) |
| NO (1) | NO842515L (da) |
| PT (1) | PT78778B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
| JPH06772B2 (ja) * | 1984-07-09 | 1994-01-05 | 鐘淵化学工業株式会社 | 3―(4―フルオロフエノキシ)プロピオニトリルを用いる6―フルオロ―4―クロマノンの製造法 |
| JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6756360B1 (en) | 1998-12-24 | 2004-06-29 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes |
| AU784370B2 (en) * | 1999-12-22 | 2006-03-23 | Metabasis Therapeutics, Inc. | Novel bisamidate phosphonate prodrugs |
| US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| US6812355B2 (en) | 2002-10-22 | 2004-11-02 | Sekhsaria Chemicals Limited | Process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
| BRPI0510394A (pt) * | 2004-05-24 | 2007-11-13 | Amgen Inc | inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 |
| US8686011B2 (en) | 2004-05-24 | 2014-04-01 | Amgen Inc. | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| JP2008510018A (ja) * | 2004-08-18 | 2008-04-03 | メタバシス・セラピューティクス・インコーポレイテッド | フルクトース−1,6−ビスホスファターゼの新規チアゾール阻害物質 |
| US7828840B2 (en) * | 2007-11-15 | 2010-11-09 | Med Institute, Inc. | Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists |
| CN115322208B (zh) * | 2021-05-10 | 2023-04-11 | 中国药科大学 | 2-氨基噻唑类衍生物及其制备方法和医药用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210756A (en) * | 1976-10-18 | 1980-07-01 | Pfizer Inc. | Tetrahydroquinoline hydantoins for chronic diabetic complications |
| US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
| US4226875A (en) * | 1979-04-02 | 1980-10-07 | Pfizer Inc. | Novel spiro-oxazolidinediones |
| US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
-
1984
- 1984-06-04 DK DK277484A patent/DK277484A/da not_active Application Discontinuation
- 1984-06-05 EP EP84106419A patent/EP0129747A3/de not_active Withdrawn
- 1984-06-08 FI FI842327A patent/FI842327L/fi not_active Application Discontinuation
- 1984-06-11 US US06/619,655 patent/US4587256A/en not_active Expired - Fee Related
- 1984-06-18 AU AU29477/84A patent/AU2947784A/en not_active Abandoned
- 1984-06-18 IL IL72139A patent/IL72139A0/xx unknown
- 1984-06-20 PT PT78778A patent/PT78778B/pt unknown
- 1984-06-20 MC MC841709A patent/MC1601A1/fr unknown
- 1984-06-20 HU HU842374A patent/HUT34509A/hu unknown
- 1984-06-21 NO NO842515A patent/NO842515L/no unknown
- 1984-06-22 ES ES533624A patent/ES8602820A1/es not_active Expired
-
1985
- 1985-03-29 ES ES541708A patent/ES8602719A1/es not_active Expired
- 1985-03-29 ES ES541705A patent/ES8602716A1/es not_active Expired
- 1985-03-29 ES ES541707A patent/ES8602718A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| HUT34509A (en) | 1985-03-28 |
| ES533624A0 (es) | 1985-12-16 |
| FI842327A0 (fi) | 1984-06-08 |
| AU2947784A (en) | 1985-01-03 |
| FI842327A7 (fi) | 1984-12-24 |
| NO842515L (no) | 1984-12-27 |
| US4587256A (en) | 1986-05-06 |
| FI842327L (fi) | 1984-12-24 |
| DK277484A (da) | 1984-12-24 |
| PT78778A (en) | 1984-07-01 |
| DK277484D0 (da) | 1984-06-04 |
| EP0129747A2 (de) | 1985-01-02 |
| PT78778B (en) | 1986-09-15 |
| IL72139A0 (en) | 1984-10-31 |
| ES541705A0 (es) | 1985-12-01 |
| ES541708A0 (es) | 1985-12-01 |
| ES8602820A1 (es) | 1985-12-16 |
| ES541707A0 (es) | 1985-12-01 |
| EP0129747A3 (de) | 1985-09-25 |
| ES8602716A1 (es) | 1985-12-01 |
| ES8602719A1 (es) | 1985-12-01 |
| ES8602718A1 (es) | 1985-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0172096A1 (fr) | Dérivés d'acylaminométhyl-3 imidazo[1,2-a]pyridines, leur préparation et leur application en thérapeutique | |
| MC1601A1 (fr) | Nouveaux derives de thiazolidine | |
| FR2612187A1 (fr) | Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant | |
| EP0073161B1 (fr) | Nouveaux dérivés de la pyrazine actifs sur le système nerveux central | |
| FR2525603A1 (fr) | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique | |
| EP0576619B1 (fr) | Compositions therapeutiques a base de derives de 1,2-dithiole-3-thione | |
| EP0803503B1 (fr) | Acides et esters de la diosmétine et compositions pharmaceutiques les contenant | |
| EP0306408A1 (fr) | Imidazo[1,2b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| EP0709383B1 (fr) | Dérivés de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les contenant | |
| FR2543140A1 (fr) | Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique | |
| EP0021940A1 (fr) | Nouveaux dérivés aminés du benzothiazole, leur procédé de préparation et leur application en thérapeutique | |
| FR2662695A1 (fr) | Amino-2 polyfluoroalcoxy-6 benzoselenazoles, leur preparation et les medicaments les contenant. | |
| EP0374041A1 (fr) | Médicaments à base de dérivés de la benzothiazolamine-2, dérivés et leur préparation | |
| EP0533827A1 (fr) | Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent. | |
| EP0348257A2 (fr) | Nouveaux dérivés d'(hétéro)aryl diazole, leur procédé de préparation et leur application en thérapeutique | |
| EP0002978A2 (fr) | Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique | |
| EP0000452B1 (fr) | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. | |
| EP0008259A1 (fr) | Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| JPS6013774A (ja) | チアゾリジン誘導体 | |
| CA1073912A (fr) | Derives de la dibenzo (de,h) quinoleine, leur preparation et les compositions qui les contiennent | |
| CA2010529A1 (fr) | Derives de la 1-arylsulfonyl 2-piperidinone, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions les renfermant | |
| FR2677477A1 (fr) | Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent. | |
| BE897156A (fr) | Derives du dithioiane, leur preparation et leur utilisation | |
| EP0161235A2 (fr) | Nouveaux dérivés de thiénopyridinone, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| EP0188150A1 (fr) | Procédé de préparation d'isomères optiques de thiazolo [3,2-a] pyrimidines, les nouveaux isomères ainsi obtenus, les compositions pharmaceutiques qui les contiennent et les intermédiaires pour mettre en oeuvre ce procédé |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid | ||
| YP | Annual fee paid |